Breaking Down THG Plc Financial Health: Key Insights for Investors

Investors tracking THG Plc will find a mix of recovery and lingering challenges in the latest figures: Q3 revenue rose by 6.3% to £405.2m, bringing year-to-date revenue to £1,188.7m, while THG Nutrition led growth with +10.0% and THG Beauty contributed +4.2%); profitability remains strained with H1 adjusted EBITDA of £24m (margin ~3.1%), an adjusted gross profit margin of 43.4% (down from 45.9% in H1 2024), an operating loss of £30.0m and a net loss of £66.1m, offset partially by a £50m gain from the sale of Claremont Ingredients and a disposal that raised £103m; balance-sheet moves include an April 2025 refinancing that cut net total leverage from 3.2x to 2.2x, extended maturities on €445m Term Loan B to Dec 2029, partial repayments totaling £74m plus €155m, and cash/available facilities of ~£278m with net debt ~£330m pre-Claremont proceeds; valuation work shows a DCF intrinsic value of £0.43 per share (versus market £0.23, implying ~46% upside) based on revenues rising from £1.75bn (2024) to £2.58bn by 2034 at a 3.9% CAGR and a WACC of 7.9%; growth levers include offline expansion (Myprotein in 34,000 doors targeting 45,000), 200+ new product launches, and margin initiatives, while risks remain around commodity-driven margin compression, high leverage (debt-to-equity 2.11 in 2024) and a reduced equity ratio of 12.0%-explore the detailed breakdowns and scenario sensitivities in the sections that follow.

THG Plc (THG.L) - Revenue Analysis

• Growth drivers: THG Nutrition led with a 10.0% rise, supported by both online and offline channel expansion.
• THG Beauty: 4.2% uplift, aided by advent season sales and stronger UK retail performance.
• Net effect of disposals: Significant headwinds to headline growth - group-level reduction of 270 basis points in Q3.

• Organic vs reported: Reported Q3 growth (6.3%) understates underlying momentum due to asset disposals; adjusting for disposals, underlying growth is stronger.
• YTD context: Modest constant currency increase of 0.3% to £1,188.7m masks divergent divisional performances and disposal impacts.

THG Plc (THG.L) - Profitability Metrics

THG's H1 2025 headline profitability shows mixed signals: an adjusted EBITDA positive but modest margin, a meaningful one-off gain, higher input costs pressuring gross margins, and continued operating and net losses.

• Adjusted EBITDA (H1 2025): £24.0m (margin ~3.1%).
• Adjusted gross profit margin (H1 2025): 43.4% vs 45.9% in H1 2024 - decline driven primarily by record whey prices.
• One-off gain: £50.0m from the sale of Claremont Ingredients, which materially supported profitability in the period.
• Operating loss (six months to 30 June 2025): £30.0m.
• Net loss (six months to 30 June 2025): £66.1m.

Management actions to support margin recovery and longer-term profitability include:

• Pricing adjustments across product lines to offset input-cost inflation.
• Targeted cost management and operational efficiencies across fulfilment and manufacturing.
• Portfolio optimisation (e.g., disposals such as Claremont) to realise value and reduce drag.
• Focus on higher-margin channels and category mix improvements.

For investor context and shareholder activity related to THG, see: Exploring THG Plc Investor Profile: Who's Buying and Why?

THG Plc (THG.L) Debt vs. Equity Structure

• Net total leverage: reduced from 3.2x to 2.2x (based on FY2024 continuing Adjusted EBITDA £92.0m).
• Refinancing objective: move toward a neutral net cash / net debt position and greater financial stability.
• Equity ratio: decreased to 12.0% in 2024, reflecting a thinner equity buffer post-period.

• Cash/equity mix: a combination of cash on the balance sheet and an equity contribution funded partial repayments (notably £74m TLA and €155m TLB portion).
• Maturity relief: TLB maturity extended to Dec 2029 and RCF extended to May 2029, lowering near-term refinancing risk.
• Leverage sensitivity: at 2.2x on £92.0m Adjusted EBITDA, a ±£10m swing in EBITDA changes leverage by ~0.24x.

THG Plc (THG.L) - Liquidity and Solvency

• Cash and available committed facilities (post-Q1 2025 refinancing): ~£278m.
• Net debt position (H1 2025, pre-Claremont disposal): ~£330m.
• Gross debt reduced by approximately £374m in H1 2025.
• Proceeds from the agreed disposal of Claremont Ingredients: £103m (expected to further lower net debt).
• Refinancing outcome: long-term committed facilities that extend maturities and enhance liquidity headroom.

• Immediate liquidity cushion of ~£278m reduces near-term refinancing risk and supports operational needs.
• The reported net debt of ~£330m reflects improvements but remains sensitive to further disposals and cash generation.
• £374m of gross-debt reduction in H1 2025 demonstrates active deleveraging efforts rather than passive balance-sheet movements.
• £103m from Claremont Ingredients will be a meaningful one‑off deleveraging cash inflow, further strengthening solvency ratios.
• Long-term committed facilities reduce rollover risk and lengthen maturities, improving covenant flexibility and investor confidence.

THG Plc (THG.L) - Valuation Analysis

• Key DCF assumptions: revenue growth from £1.75bn to £2.58bn (3.9% CAGR), net margins improving from -10% to 3%, terminal growth embedded in long-term rates consistent with WACC 7.9%.
• Profitability trajectory: break-even and modest positive net margins by 2034 drive a large portion of the DCF upside versus current negative margins.
• Capital structure / discounting: a 7.9% WACC reflects elevated execution and market risks relative to low-beta peers, compressing present value of distant cash flows.

• Sensitivity notes: valuation is highly sensitive to (a) revenue CAGR, (b) timing and magnitude of margin recovery, and (c) WACC shifts - small percentage-point changes materially alter intrinsic value.
• Investor takeaway: the DCF suggests upside if growth and margin assumptions hold; downside risk emerges from slower revenue, prolonged negative margins, or higher cost of capital.

THG Plc (THG.L) - Risk Factors

• Revenue trends: management reports and market data show a sustained decline in top-line sales, with recent year-on-year revenue contraction in the mid-to-high single digits to mid-teens range, driven by weaker direct-to-consumer demand and portfolio recalibration.
• Profitability: the group continues to report operating and net losses in recent reporting periods; elevated input costs (notably whey) have materially compressed gross margins versus prior periods.
• Leverage: debt metrics are elevated - debt-to-equity stood at 2.11 in 2024 - increasing interest burden and refinancing risk.
• Capital structure and solvency: the equity ratio declined to 12.0% in 2024, reflecting reduced financial cushion and greater reliance on external capital.
• Margin recovery efforts: management has prioritized pricing actions, SKU and channel optimization, and cost-base reduction initiatives to arrest margin declines.
• Cash flow and deleveraging focus: initiatives to improve working capital, divest non-core assets and reduce gross debt are central to restoring solvency and lowering refinancing risk.

• Commodity exposure: whey and other nutraceutical inputs have seen price spikes that reduced gross margins; sensitivity analysis indicates a material margin impact for sustained elevated commodity pricing.
• Refinancing and covenant risk: high leverage increases the probability of covenant scrutiny and refinancing at higher costs if cash flow recovery stalls.
• Execution risk: margin improvement and deleveraging plans depend on effective price realization, cost cuts, and asset disposals - any slippage prolongs losses and capital strain.

THG Plc (THG.L) - Growth Opportunities

• Nutrition momentum: THG Nutrition reported a 10.0% year-on-year revenue increase in Q3 2025, driven by balanced online and offline channel growth.
• Beauty resilience: THG Beauty delivered a 4.2% year-on-year revenue increase in Q3 2025, supported by advent sales and stronger UK retail performance.
• Offline retail scale-up: Myprotein is now stocked in over 34,000 retail doors globally, with a target of 45,000 doors by year-end, accelerating omnichannel reach.

• Margin focus: Management is pursuing pricing, cost control and product-mix strategies to improve gross and operating margins-key given past margin pressure in the sector.
• Distribution and visibility: FTSE 250 inclusion is expected to attract index and passive flows and broaden the investor base, which can support liquidity and valuation.
• Cross-channel synergies: Expanding offline distribution (from 34k to 45k doors) complements strong ecommerce capabilities, reducing single-channel concentration risk.